A prospective randomized open-label blinded-endpoint (PROBE) trial comparing Micardis (telmisartan) (40-80-80 mg QD) and ramipril (2.5-5-10 mg QD) in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring (ABPM)
Phase of Trial: Phase IV
Latest Information Update: 03 Dec 2008
At a glance
- Drugs Ramipril; Telmisartan
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 03 Dec 2008 Last checked against ClinicalTrials.gov record.
- 29 Mar 2007 New trial record.